Expression of transforming growth factor beta (TGF-b1) by human preterm lung inflammatory cells

Life Sci. 2006 Nov 17;79(25):2349-56. doi: 10.1016/j.lfs.2006.07.040. Epub 2006 Aug 11.

Abstract

Using a previously published model of human BPD this study examines whether preterm lung inflammatory cells produce transforming growth factor beta 1 (TGF-beta1), a cytokine pivotal in pathogenesis of bronchopulmonary dysplasia (BPD), and whether TGF-beta1 expression is regulated by inflammation. Lung inflammatory cells (neutrophils and macrophages) recovered in the broncho-alveolar (BAL) fluid of premature infants intubated for respiratory distress after birth expressed TGF-b1 mRNA and protein. Total and bioactive TGF-beta1 were abundantly found in the BAL fluid of the same infants. In cell culture stimulation by lipopolysaccharide (LPS) did not result in any further expression of total or bioactive TGF-beta1 by neonatal lung inflammatory cells over constitutive concentrations. In conclusion, lung inflammatory cells from premature infants are a source of TGF-beta1 but LPS does not regulate TGF-b1 production in these cells.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bronchoalveolar Lavage Fluid
  • Bronchopulmonary Dysplasia / metabolism*
  • Cells, Cultured
  • Female
  • Gene Expression Regulation / drug effects
  • Gene Expression Regulation / physiology*
  • Humans
  • Infant, Newborn
  • Lipopolysaccharides / pharmacology
  • Lung / cytology*
  • Macrophages / drug effects
  • Macrophages / metabolism*
  • Neutrophils / drug effects
  • Neutrophils / metabolism*
  • Pregnancy
  • Premature Birth*
  • RNA, Messenger / metabolism
  • Reverse Transcriptase Polymerase Chain Reaction
  • Transforming Growth Factor beta1 / genetics*

Substances

  • Lipopolysaccharides
  • RNA, Messenger
  • Transforming Growth Factor beta1